A carregar...
Treatment of relapsed and refractory Hodgkin Lymphoma
Despite the high first line cure rates in patients with Hodgkin Lymphoma (HL) still 10–20% of patients suffer from relapsed or refractory disease. High dose chemotherapy (HDCT) followed by autologous stem cell transplant (ASCT) is standard of care for suitable patients with relapsed or refractory HL...
Na minha lista:
| Publicado no: | Semin Hematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5637390/ https://ncbi.nlm.nih.gov/pubmed/27496309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.seminhematol.2016.05.010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|